Cargando…
Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
How circulating inflammatory mediators change upon sepsis progression has not been studied. We studied the follow-up changes of circulating vasoactive peptides and cytokines until the improvement or the worsening of a patient and progression into specific organ dysfunctions. In a prospective study,...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101577/ https://www.ncbi.nlm.nih.gov/pubmed/28455780 http://dx.doi.org/10.1007/s10096-017-2988-6 |
_version_ | 1783511654426738688 |
---|---|
author | Ioakeimidou, A. Pagalou, E. Kontogiorgi, M. Antoniadou, E. Kaziani, K. Psaroulis, K. Giamarellos-Bourboulis, E. J. Prekates, A. Antonakos, N. Lassale, P. Gogos, C. |
author_facet | Ioakeimidou, A. Pagalou, E. Kontogiorgi, M. Antoniadou, E. Kaziani, K. Psaroulis, K. Giamarellos-Bourboulis, E. J. Prekates, A. Antonakos, N. Lassale, P. Gogos, C. |
author_sort | Ioakeimidou, A. |
collection | PubMed |
description | How circulating inflammatory mediators change upon sepsis progression has not been studied. We studied the follow-up changes of circulating vasoactive peptides and cytokines until the improvement or the worsening of a patient and progression into specific organ dysfunctions. In a prospective study, concentrations of tumor necrosis factor-alpha (TNFα), interleukin (IL)-6, IL-8, IL-10, interferon-gamma (IFNγ), endocan and angiopoietin-2 (Ang-2) were measured in serum by an enzyme immunoassay in 175 patients at baseline; this was repeated within 24 h upon progression into new organ dysfunction (n = 141) or improvement (n = 34). Endocan and Ang-2 were the only parameters that were significantly increased among patients who worsened. Any increase of endocan was associated with worsening with odds ratio 16.65 (p < 0.0001). This increase was independently associated with progression into acute respiratory distress syndrome (ARDS) as shown after logistic regression analysis (odds ratio 2.91, p: 0.002). Changes of circulating cytokines do not mediate worsening of the critically ill patients. Instead endocan and Ang2 are increased and this may be interpreted as a key-playing role in the pathogenesis of ARDS and septic shock. Any increase of endocan is a surrogate of worsening of the clinical course. |
format | Online Article Text |
id | pubmed-7101577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-71015772020-03-31 Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction Ioakeimidou, A. Pagalou, E. Kontogiorgi, M. Antoniadou, E. Kaziani, K. Psaroulis, K. Giamarellos-Bourboulis, E. J. Prekates, A. Antonakos, N. Lassale, P. Gogos, C. Eur J Clin Microbiol Infect Dis Original Article How circulating inflammatory mediators change upon sepsis progression has not been studied. We studied the follow-up changes of circulating vasoactive peptides and cytokines until the improvement or the worsening of a patient and progression into specific organ dysfunctions. In a prospective study, concentrations of tumor necrosis factor-alpha (TNFα), interleukin (IL)-6, IL-8, IL-10, interferon-gamma (IFNγ), endocan and angiopoietin-2 (Ang-2) were measured in serum by an enzyme immunoassay in 175 patients at baseline; this was repeated within 24 h upon progression into new organ dysfunction (n = 141) or improvement (n = 34). Endocan and Ang-2 were the only parameters that were significantly increased among patients who worsened. Any increase of endocan was associated with worsening with odds ratio 16.65 (p < 0.0001). This increase was independently associated with progression into acute respiratory distress syndrome (ARDS) as shown after logistic regression analysis (odds ratio 2.91, p: 0.002). Changes of circulating cytokines do not mediate worsening of the critically ill patients. Instead endocan and Ang2 are increased and this may be interpreted as a key-playing role in the pathogenesis of ARDS and septic shock. Any increase of endocan is a surrogate of worsening of the clinical course. Springer Berlin Heidelberg 2017-04-28 2017 /pmc/articles/PMC7101577/ /pubmed/28455780 http://dx.doi.org/10.1007/s10096-017-2988-6 Text en © Springer-Verlag Berlin Heidelberg 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Ioakeimidou, A. Pagalou, E. Kontogiorgi, M. Antoniadou, E. Kaziani, K. Psaroulis, K. Giamarellos-Bourboulis, E. J. Prekates, A. Antonakos, N. Lassale, P. Gogos, C. Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction |
title | Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction |
title_full | Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction |
title_fullStr | Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction |
title_full_unstemmed | Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction |
title_short | Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction |
title_sort | increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101577/ https://www.ncbi.nlm.nih.gov/pubmed/28455780 http://dx.doi.org/10.1007/s10096-017-2988-6 |
work_keys_str_mv | AT ioakeimidoua increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT pagaloue increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT kontogiorgim increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT antoniadoue increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT kazianik increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT psaroulisk increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT giamarellosbourboulisej increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT prekatesa increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT antonakosn increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT lassalep increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT gogosc increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction AT increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction |